Research Article
Evaluation of Repeat ERCP: Analysis of a Four-Year Experience
Ahmet Burak TOROS1*, Besir KESICI1, Ferit ARGUN2, Serkan GOKCAY2, Serkan SARI3, Hasan BEKTAS3, Yavuz Selim SARI3 and Ozhan OZCAN31Istanbul Education and Research Hospital, Department of Gastroenterology, Istanbul, Turkey
2Istanbul Education and Research Hospital, Department of Internal Diseases, Istanbul, Turkey
3Istanbul Education and Research Hospital, Department of General Surgery, Istanbul, Turkey
- *Corresponding Author:
- Ahmet Burak Toros, MD
Mecidiye mah, M. Sadettin sok
No: 3, D: 4, Ortakoy, 34347
Istanbul, Turkey
Tel: 90-535 783 58 29
Fax: 90-212 327 33 84
E-mail: aburaktoros@yahoo.com
Received date: February 03, 2012; Accepted date: June 28, 2012; Published date: June 30, 2012
Citation: TOROS AB, KESİCİ B, ARGUN F, GOKCAY S, ERSOZ F, et al. (2012) Evaluation of Repeat ERCP: Analysis of a Four-Year Experience. J Gastroint Dig Syst 2:116 doi:10.4172/2161-069X.1000116
Copyright: © 2012 TOROS AB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
In this trial, a total of 1010 ERCP procedures performed in 410 patients at the endoscopy department of our hospital between 2006 and 2010, were retrospectively evaluated. The age, gender, complaints, pre-procedure diagnosis, the radiologic and clinical results, number of procedure repetitions and the final diagnosis were assessed. The local Ethics Committee approved this retrospective study protocol. All of the procedures were performed by the same team of endoscopists with compatible levels of ERCP experience (Mean 5 years). At our department, pethidine HCl (0.3-0.5 mg/kg), midazolam (0.03-0.07 mg/kg) and hyoscine-N-butylbromide (0.3-0.6 mg/kg) are used in the ERCP procedures for premedication and additionally, cefazolin 1 gram intravenous is routinely administered for prophyllaxis one hour before the examination. During the procedure, oxygen saturation and heart rate are monitored by pulse-oximeter. The patients were those admitted to our hospital or referred from other healthcare centers. Statistical assessment was performed by evaluating the first ERCP procedures and the repeat procedure records. Chi-square test was used to statistically analyze the results. The level of significance was set at p<0.05.